Jack Wei Chieh Tan
Overview
Explore the profile of Jack Wei Chieh Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McEvoy J, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, et al.
Eur Heart J
. 2024 Aug;
45(39):4184-4196.
PMID: 39212219
Background And Aims: INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in...
2.
Goh R, Chong B, Jayabaskaran J, Jauhari S, Chan S, Kueh M, et al.
Lancet Reg Health West Pac
. 2024 Aug;
49:101138.
PMID: 39100533
Background: Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050. Methods: Data...
3.
Tan J, Yeo T, Tan D, Chua T, Yeo K, Koh N, et al.
Ann Acad Med Singap
. 2024 Jun;
53(1):23-33.
PMID: 38920212
Introduction: In 2022, the Minister for Health of Singapore launched Healthier SG, a national strategy in championing the shift towards a population health approach. Method: The Singapore Heart Foundation conducted...
4.
Putra T, Widodo W, Putra B, Soerianata S, Yahya A, Tan J
Postgrad Med J
. 2024 Jun;
100(1189):827-835.
PMID: 38899828
Background: The utilization of postdilatation in primary percutaneous coronary intervention (PCI) is feared to induce suboptimal coronary blood flow and compromise the outcome of the patients. This meta-analysis sought to...
5.
Tern P, Yeo K, Tan J, Chin C, Tan R, Yap J
Expert Rev Cardiovasc Ther
. 2024 May;
22(6):203-215.
PMID: 38739469
Introduction: Anticoagulants play a vital role as part of the antithrombotic therapy of myocardial infarction and are complementary to antiplatelet therapies. In the acute setting, the rationale for their use...
6.
Wong J, Wang L, Hasegawa K, Ho K, Huang Z, Teo L, et al.
Eur Heart J Open
. 2024 Apr;
4(2):oeae025.
PMID: 38659665
Aims: Aging-related cardiovascular disease and frailty burdens are anticipated to rise with global aging. In response to directions from major cardiovascular societies, we investigated frailty knowledge, awareness, and practices among...
7.
Chew N, Chong B, Kuo S, Jayabaskaran J, Cai M, Zheng H, et al.
Lancet Reg Health West Pac
. 2023 Sep;
37:100803.
PMID: 37693863
Background: Understanding the trajectories of metabolic risk factors for acute myocardial infarction (AMI) is necessary for healthcare policymaking. We estimated future projections of the incidence of metabolic diseases in a...
8.
Fong K, Low C, Chan Y, Ho K, Keh Y, Chin C, et al.
Am J Cardiol
. 2023 Aug;
205:369-378.
PMID: 37639763
Patients with chronic kidney disease (CKD) have traditionally been excluded from randomized trials. We aimed to compare percutaneous coronary intervention versus conservative management, and early intervention (EI; within 24 hours...
9.
Putra T, Rodriguez-Fernandez R, Widodo W, Elfiana M, Laksono S, Nguyen Q, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1230894.
PMID: 37564912
Rheumatic heart disease (RHD) remains a significant cardiovascular burden in the world even though it is no longer common in affluent countries. Centuries of history surrounding this disease provide us...
10.
Sia C, Ko J, Zheng H, Ho A, Foo D, Foo L, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1142078.
PMID: 37435049
Introduction: Obesity is an important risk factor for acute myocardial infarction (AMI), but the interplay between metabolic health and obesity on AMI mortality has been controversial. In this study, we...